Fig. 2From: Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsMSC-derived paracrine factors mediate immunomodulatory functions, particularly towards T lymphocytes, in preclinical animal studies of various immune-and inflammation-mediated diseasesBack to article page